Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

HSV Encephalitis associated with off-label Rituximab use in a case of relapsing multiple sclerosis.
Multiple Sclerosis
P5 - (-)
390
Authors/Disclosures
Aparna Vaddiparti, MD (UAB Medicine, Department of Neurology, Division of Epilepsy)
PRESENTER
Dr. Vaddiparti has nothing to disclose.
Bharti Manwani, MD (University of Texas Health Science Center Houston, McGovern Medical School) Dr. Manwani has nothing to disclose.
Catherine Hosley, MD (Hartford Hospital) No disclosure on file
Matthew A. Tremblay, MD (RWJ Barnabas Health) Dr. Tremblay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Dr. Tremblay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals Inc. Dr. Tremblay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Tremblay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Tremblay has received research support from Biogen Inc. Dr. Tremblay has received publishing royalties from a publication relating to health care.